SERUM MIRNAS FOR THE PROGNOSIS OF PROSTATE CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 18, 2016
app pub date -
Oct 15, 2014
filing date -
Oct 15, 2013
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A prostate cancer prognostic serum miRNA panel associated with low-risk prostate cancer is provided that improves prognosis determination and the selection of an appropriate treatment regime. More particularly, the prostate cancer prognostic miRNAs can distinguish between lowgrade and high-grade prostate cancers.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully